P D Markham

3.6k citations

35 papers · 3.0k indexed · 1 hit paper · h-index 24

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 14
- HIV Research and Treatment 14
Agronomy and Crop Science 7
- Animal Disease Management and Epidemiology 7

Co-authors: Robert C. Gallo (17 shared papers)Paolo Lusso (6 shared papers)M S Reitz (5 shared papers)S. Zaki Salahuddin (7 shared papers)G M Shearer (3 shared papers)R Gendelman (4 shared papers)Barbara Ensoli (4 shared papers)R Pal (3 shared papers)
Journals: Journal of Virology (11 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Clinical Investigation (3 papers)The Journal of Immunology (2 papers)Journal of Allergy and Clinical Immunology (1 paper)
Partner nations: United States Italy Sweden

In The Last Decade

P D Markham

35 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX 1986 · 651 citations

Peers

Countries citing papers authored by P D Markham

Since Specialization

Citations

This map shows the geographic impact of P D Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P D Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P D Markham more than expected).

Fields of papers citing papers by P D Markham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P D Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P D Markham. The network helps show where P D Markham may publish in the future.

Co-authors

The 25 scholars most cited alongside P D Markham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P D Markham Line = papers co-authored together P D Markham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX The Lancet ·Robert Yarchoan, KentJ. Weinhold, H. Kim Lyerly, Edward P. Gelmann, RobertM. Blum, G M Shearer, Hiroaki Mitsuya, JerryM. Collins, CharlesE. Myers, R W Klecker, P D Markham, DavidT. Durack, Sandra Nusinoff Lehrman, DavidW. Barry, MargaretA. Fischl, RobertC. Gallo, DaniP. Bolognesi, Samuel Broder Hit paper breakdown →	1986	651
2	In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). The Journal of Experimental Medicine ·Paolo Lusso, P D Markham, Erwin Tschachler, Fulvia Veronese, S. Zaki Salahuddin, D. V. Ablashi, Savita Pahwa, Kai Krohn, Rosella Gallo	1988	254
3	Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 Journal of Virology ·Paolo Lusso, Fiorenza Cocchi, Claudia Balotta, P D Markham, A Louie, Patrizia Farci, R Pal, Robert C. Gallo, M S Reitz	1995	233
4	Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages Journal of Virology ·M Robert-Guroff, M Popovic, Samuel Gartner, P D Markham, Robert C. Gallo, M S Reitz	1990	187
5	ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A01) Delay Simian Immunodeficiency Virus SIV_mac-Induced Immunodeficiency Journal of Virology* ·R Pal, David Venzon, Norman L. Letvin, Sampa Santra, David C. Montefiori, N. R. Miller, Elżbieta Tryniszewska, Mark G. Lewis, Thomas C. VanCott, Vanessa M. Hirsch, Ruth Woodward, Andrew Gibson, Michele Grace, Eric Dobratz, P D Markham, Zdeněk Hel, János Nacsa, Michel Klein, J. Tartaglia, Genoveffa Franchini	2002	179
6	Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. Journal of Clinical Investigation ·Valeria Fiorelli, R Gendelman, Felipe Samaniego, P D Markham, Barbara Ensoli	1995	139
7	Human B-lymphotropic virus (human herpesvirus-6) Journal of Virological Methods ·Dharam V. Ablashi, Steven F. Josephs, Aby Buchbinder, Kiki B. Hellman, Shuji Nakamura, T Llana, Paolo Lusso, Mark H. Kaplan, John E. Dahlberg, Sarfraz Memon, Fouladi Abbasali Imam, Kristinë L. Ablashi, P D Markham, B. Kramarsky, G. R. F. Krueger, Peter Biberfeld, Flossie Wong‐Staal, S. Zaki Salahuddin, Robert C. Gallo	1988	128
8	Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIV_mac251: Dependence on Route of Challenge Exposure Journal of Virology ·John M. Benson, Claire Chougnet, Marjorie Robert-Guroff, David C. Montefiori, P D Markham, G M Shearer, Robert C. Gallo, Martin Cranage, Enzo Paoletti, Keith Limbach, David Venzon, James Tartaglia, Genoveffa Franchini	1998	122
9	Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proceedings of the National Academy of Sciences ·S. Zaki Salahuddin, P D Markham, M Popovic, M. G. Sarngadharan, Sharon Orndorff, A Fladagar, Arpita Patel, Julian Gold, Robert C. Gallo	1985	120
10	Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. Journal of Clinical Investigation ·Barbara Ensoli, P D Markham, V Kao, Giovanni Barillari, Valeria Fiorelli, R Gendelman, Mark Raffeld, G. Zon, Robert C. Gallo	1994	106
11	Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. PubMed ·Giovanni Barillari, Cecilia Sgadari, Clelia Palladino, R Gendelman, Antonella Caputo, Cindy Morris, B.C. Nair, P D Markham, André E. Nel, Michael Stürzl, Barbara Ensoli	1999	104
12	Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3 The Journal of Immunology ·Paolo Lusso, Mauro Malnati, Andrea De Maria, Claudia Balotta, Susan E. DeRocco, P D Markham, Robert C. Gallo	1991	98
13	Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. Proceedings of the National Academy of Sciences ·Fulvia Veronese, M. G. Sarngadharan, Rukhsana Rahman, P D Markham, M Popovic, Anne J. Bodner, Robert C. Gallo	1985	72
14	Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia Virology ·Robert C. Gallo, Robert E. Gallagher, Flossie Wong‐Staal, Tadao Aoki, P D Markham, H. Schetters, Francis W. Ruscetti, Marion G. Valerio, M. J. Walling, Roderic O’Keeffe, W. Carl Saxinger, R. Guy Smith, David Gillespie, M. S. Reitz	1978	70
15	Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations Journal of General Virology ·A. D. Cristillo, M. G. Ferrari, Lauren Hudacik, Brad Lewis, Lindsey Galmin, B.D. Bowen, Darby Thompson, Nikolai Petrovsky, P D Markham, R Pal	2010	58
16	Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II Journal of Virology ·Adriana A. Giri, P D Markham, Laura Digilio, GREG HURTEAU, Robert C. Gallo, Genoveffa Franchini	1994	57
17	Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates Journal of Virology ·Marjorie Robert-Guroff, Kristine Aldrich, Rebecca R. Muldoon, T L Stern, Geetha P. Bansal, Thomas J. Matthews, P D Markham, Robert C. Gallo, Genoveffa Franchini	1992	52
18	HTLV‐III infection of EBV‐genome‐positive B‐lymphoid cells with or without detectable T4 antigens International Journal of Cancer ·S. Zaki Salahuddin, Elizabeth Hunter, (unknown), P D Markham, Robert C. Gallo, Dharam V. Ablashi, Matthew A. Gonda	1987	50
19	Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Journal of Clinical Investigation ·G M Shearer, S. Zaki Salahuddin, P D Markham, L J Joseph, Susan Payne, P W Kriebel, Daniel Bernstein, William E. Biddison, M. G. Sarngadharan, Robert C. Gallo	1985	46
20	Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence Journal of Virology ·Franco Lori, LEOTA HALL, Paolo Lusso, M Popovic, P D Markham, Genoveffa Franchini, M S Reitz	1992	33

About P D Markham

P D Markham is a scholar working on Virology, Agronomy and Crop Science, Immunology, Animal Science and Zoology and Immunology and Allergy, having authored 35 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), T-cell and Retrovirus Studies (10 papers), Virus-based gene therapy research (7 papers), Animal Disease Management and Epidemiology (7 papers), Herpesvirus Infections and Treatments (6 papers), Animal Virus Infections Studies (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (1.0k citations), Immunology (944 citations), Epidemiology (1.1k citations) and Oncology (614 citations). P D Markham has collaborated with scholars based in United States, Italy and Sweden. Frequent co-authors include Robert C. Gallo, Paolo Lusso, M S Reitz, S. Zaki Salahuddin, G M Shearer, R Gendelman, Barbara Ensoli, R Pal, Valeria Fiorelli and Claudia Balotta. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact